“Early attention to pain and symptoms in those with cancer improves both quality of life and survival. Opioid medications are the mainstay treatment of cancer-related pain.
Cannabinoids are increasingly used as adjunctive treatments for cancer pain, but clinical evidence supporting their use as an “opioid sparing agent” or to improve quality of life is as yet unknown.
Our study sought to determine if the addition of cannabinoids (medical cannabis) resulted in the reduction of the average opioid dose required for pain control, and improve self-reported quality of life indices.
Patients with cancer pain benefited from the addition of cannabinoids.
The average opioid dose decreased following access to medical cannabis.
Self-reported ratings of several quality of life indicators showed statistically significant improvement.
Our study shows a signal that cannabinoids may reduce cancer patients’ reliance on opioids to control pain.
Further prospective controlled studies are needed to further elucidate the role of cannabinoids in the treatment of cancer pain.”
